GlassScriptPhysician profile
Cheryl A Potter
NPI 1982693578
$4,061.25
in general payments reported to CMS, 2019-2025
39 companies · $452 in 2025
The $452 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $448 · 2021: $614 · 2022: $560 · 2023: $972 · 2024: $572 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,996.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $533.39 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $432.83 | 2023-2025 | Myfembree |
| Millicent US INC | $391.42 | 2020-2025 | Intrarosa, Femlyv, Femring |
| Astellas Pharma US INC | $310.93 | 2022-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $259.11 | 2019-2025 | Slynd |
| Therapeuticsmd, INC. | $231.59 | 2019-2022 | |
| Pfizer INC. | $169.59 | 2019-2024 | |
| Avion Pharmaceuticals | $122.13 | 2019-2023 | Balcoltra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $108.53 | 2019-2024 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $106.34 | 2019-2023 | |
| Agile Therapeutics, INC. | $101.37 | 2021-2023 | Twirla |
| Ethicon US, LLC | $93.75 | 2019-2023 | Ethicon, Stratafix, Enseal X1 |
| Minerva Surgical, INC | $93.03 | 2021-2023 | |
| Shield Therapeutics INC | $92.04 | 2022-2024 | |
| Myovant Sciences INC. | $82.94 | 2021-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $69.69 | 2022-2023 | |
| Hologic Sales and Service, LLC | $69.42 | 2022-2024 | Aptima |
| Amag Pharmaceuticals, INC. | $65.22 | 2019-2020 | |
| Axonics, INC. | $61.91 | 2022-2023 | Bulkamid, Axonics |
| Evofem Biosciences, INC. | $61.11 | 2020-2021 | |
| Allergan, INC. | $60.41 | 2019-2020 | |
| Baxter Healthcare | $60.34 | 2021-2024 | Floseal |
| Medtronic, INC. | $45.72 | 2021-2024 | V-Loc 180 |
| Merck Sharp & Dohme LLC | $42.54 | 2023-2024 | Gardasil 9, Gardasil |
| Mylan Pharmaceuticals INC. | $40.53 | 2022 | |
| Lupin INC. | $40.17 | 2019-2020 | |
| Becton, Dickinson and Company | $35.07 | 2023 | Bd Onclarity |
| Aspira Women'S Health INC | $34.27 | 2022-2023 | Ova1 |
| Organon LLC | $29.88 | 2025 | Nexplanon |
| Myriad Women'S Health, INC. | $28.58 | 2023 | Myrisk |
| Meditrina | $27.67 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.65 | 2020 | |
| Vertical Pharmaceuticals, LLC | $24.37 | 2019 | |
| Exact Sciences Corporation | $22.68 | 2025 | Cologuard Collection Kit |
| Mycovia Pharmaceuticals, INC. | $20.24 | 2023 | Vivjoa |
| Davol INC. | $20.13 | 2022 | |
| Boston Scientific Corporation | $18.60 | 2019 | |
| Duchesnay USA Incorporated | $14.22 | 2019 | |
| Convatec INC. | $13.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Potter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.